Immune restoration disease in HIV patient

Emerging Infectious Diseases

Volumn 12, Issue 4, 2006, Pages 689-691

  Jenkins, Neil E ^a,b,c   Beadsworth, Mike B J ^a   Anson, James J ^a   Nye, Fred J ^a   Martlew, Vanessa J ^a   Beeching, Nick J ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b Royal Liverpool University Hospital ^*

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; COTRIMOXAZOLE; EFAVIRENZ; ETHAMBUTOL; LAMIVUDINE; RIFAMPICIN; ZIDOVUDINE;

ARTICLE; BRONCHITIS; BRONCHUS BIOPSY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; LABORATORY TEST; LUNG GRANULOMATOSIS; LUNG INFECTION; MYCOBACTERIUM MICROTI; NEOPLASM; THORAX RADIOGRAPHY; TUBERCULOSIS;

EID: 33645466463     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1204.050455     Document Type: Article

References (14)

1. Goyal M, Saunders NA, van Embden JD, Young DB, Shaw RJ. Differentiation of Mycobacterium tuberculosis isolates by spoligo-typing and IS6110 restriction fragment length polymorphism. J Clin Microbiol. 1997;35:647-51.
2. Cavanagh R, Begon M, Bennett M, Ergon T, Graham IM, de Haas PEW, et al. Mycobacterium microti infection (vole tuberculosis) in wild rodent populations. J Clin Microbiol. 2002;40:3281-5.
3. Wells AQ, Oxon DM. Tuberculosis in wild voles. Lancet. 1937;1:1221.
4. Horstkotte MA, Sobottka I, Schewe CK, Schafer P, Laufs R, Rusch-Gerged S, et al. Mycobacterium microti llama-type infection presenting as pulmonary tuberculosis in a human immunodeficiency virus-positive patient. J Clin Microbiol. 2001;39:406-7.
5. Niemann S, Richter E, Dalügge-Tamm H, Schlesinger H, Graupner D, Königstein B, et al. Two cases of Mycobacterium microti-derived tuberculosis in HIV-negative immunocompetent patients. Emerg Infect Dis. 2000;6:539-42.
6. Foudraine NA, van Soolingen D, Noordhoek GT, Reiss P. Pulmonary tuberculosis due to Mycobacterium microti in a human immunodeficiency virus-infected patient. Clin Infect Dis. 1998;27:1543-4.
7. Van Soolingen D, van der Zanden AGM, de Haas PEW, Noordhoek GT, Kiers A, Foudraine NA, et al. Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol. 1998;36:1840-5.
8. Huard RC, Oliveira Lazzarini LC, Butler WR, van Soolingen D, Ho JL. PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J Clin Microbiol. 2003;41:1637-50.
9. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005;5:361-73.
10. DeSimone JA, Pomerantz RJ, Babichak TJ. Inflammatory reactions in HIV-1 infected patients after initiation of highly active antiretroviral therapy. Ann Intern Med. 2000;133:447-54.
11. Bartley PB, Allworth AM, Eisen DP. Mycobacterium avium complex causing endobronchial disease in AIDS patients after partial immune restoration. Int J Tuberc Lung Dis. 1999;3:1132-6.
12. Price P, Mathiot N, Krueger R, Stone S, Keane NM, French M. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol. 2001;22:279-87.
13. French MA, Price P, Stone SF. Immune restoration disease after retroviral therapy. AIDS. 2004;18:1615-27.
14. Dheda K, Lampe FC, Johnson MA, Lipman MC. Outcome of HIVassociated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis. 2004;190:1670-6.